A tool for interrupting Malaria Transmission
The PRINOGAM trial on the use of low doses of primaquine to interrupt malaria transmission from human to mosquitoes in individuals not sick but with a malaria infection has been successfully completed.
Introducing MRC Unit The Gambia’s new newsletter, Our Science
We are excited to announce the release of our new quarterly newsletter, Our Science, and brochure that have now been posted on our website. Our Science focuses on the research we carry out hence the title and brings your attention to our achievements.
Pfizer Receives European Approval for New Multi-Dose Vial Presentation of Prevenar 13 – conducted by MRC Unit The Gambia
On Wednesday, April 6, 2016, Pfizer announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) approved a new four-dose, multi-dose vial (MDV) presentation of Prevenar 13 (pneumococcal polysaccharide conjugate vaccine [13-valent, adsorbed]).
MRC Unit The Gambia Launched 5 year Strategic Plan
The launch of the MRC Unit The Gambia’s 2016-2021 Quinquennial (5-year strategic plan) on the 1 April 2016 was successfully attended by over 400 staff, collaborators and partners. The event offered the opportunity to share our vision, plan for training and highlight recent success stories.
MRC Unit The Gambia Tuberculosis (TB) research and the World TB day celebration
The MRC Unit The Gambia (MRCG), has a long standing interest in tuberculosis (TB) occurring in households and has over the years maintained the TB research platform through core funding and a program grant focused on children with TB.
MRC Unit The Gambia hosts B3Africa – Ethics & Regulation Workshop
The MRC Unit The Gambia (MRCG) will be hosting a ‘Bridging Biobanking and Biomedical Research across Europe and Africa’ (B3Africa) international workshop from 11-13 April 2016 at Kairaba Hotel.
Maternal and Neonatal Immunisation in The Gambia
Neonatal and early infant morbidity and mortality remains the highest in low and middle-income countries, often caused by infections that could be prevented by vaccines.
Improving MRC Unit The Gambia’s Brand Impact
In an effort to improve our impact and position as a leader in health research and to address inconsistencies with the way our name and logo are used, we have revised our name to MRC Unit The Gambia (without a comma), which should be used in the first instance. We can also be referred to […]
Our Science: Spring 2016
MRC Unit The Gambia Launches’ 2016-2021 Quinquennial
The MRC Unit The Gambia (MRCG), is internationally recognised for delivering excellent global health research in Africa and beyond. Building on these achievements, for the next 5 years, MRCG will be launching the 2016-2021 Quinquennial (5 year strategic plan) on the 1 April 2016 at 11am at our main site in Fajara.
MRC Unit The Gambia Commissions a New Unit Video
The MRC Unit The Gambia (MRCG) is internationally recognised for its immense contribution in tackling infectious diseases of global public health importance in sub Saharan Africa. The scientific vision of MRCG is to contribute to the post-2015 sustainable development agenda by producing evidence base research to improve health in West Africa and beyond.
Global Role and Burden of Influenza in Pediatric Respiratory Hospitalisations
A new study titled: Global Role and Burden of Influenza in Pediatric Respiratory Hospitalizations: A Systematic Analysis (GRIPP) appeared in PLoS Medicine on 22 March 2016 confirming that increasing influenza vaccination coverage among young children and pregnant women could reduce this burden and protect infants less than 6 months.